New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 12, 2024 - The FDA approved Novartis’ Entresto Sprinkle (sacubitril/valsartan), a new oral pellets within capsule formulation of Entresto.
Download PDF
Return to publications
